Market Trends of France Endoscopy Devices Industry
This section covers the major market trends shaping the France Endoscopy Devices Market according to our research experts:
Cardiology is Expected to Witness Strong Growth Over the Forecast Period
Applications of endoscopy devices in cardiology are expected to increase and contribute to the growth of the market studied in the coming years. This is majorly attributed to the increasing prevalence of cardiovascular diseases across the country.
As per the data published in 2022 by Foundation De France, every four minutes, a person from France faces a cardiovascular event. These conditions are currently France's second-leading cause of death and are affecting younger segments of the population. The Foundation de France has been funding research to better understand, anticipate, and treat cardiovascular problems for more than 20 years. With the presence of such organizations in the country, awareness about cardiovascular diseases (CVD), and their related treatment options, the market is anticipated to witness significant growth in France over the forecast period.
Obesity in the country is fueling the number of people suffering from CVD. For instance, as per the Foundation De France 2022 data, around 17% of the young people in France are obese, and a large share of these people have cardiovascular diseases. According to the article published in November 2021, there were around 94,408 cases of cardiovascular diseases and interventions in 2020 in France. This high number of cardiac disease patients is propelling the market's growth.
Hence, with the increasing burden of cardiovascular diseases in France, the segment is likely to witness strong growth over the forecast period.
High Prevalence of Diseases that Require Endoscopy is also Contributing to the Market's Growth
The increase in incidences of chronic diseases is the main factor responsible for the market's growth in the historical and forecast periods. In France, researchers have made several efforts to cope with various respiratory diseases that are idiopathic. For instance, according to the data from the Respiratory Medicine and Research Journal published in August 2022, the management of diseases such as idiopathic pulmonary fibrosis has evolved significantly in France in recent years. This is majorly attributed to the improved guidelines on disease diagnosis and treatment coupled with effective disease management practices in the country. Hence, with the efforts of French researchers in enabling effective diagnostic methods for idiopathic pulmonary diseases, it is believed that there will be a growing demand for endoscopy devices which will boost the market's growth in the coming years.
Furthermore, according to the PubMed data published in September 2022, in the randomized study of patients with mild to moderate dysplasia across 17 French hospitals, it was observed that people with dysplasia are at a higher risk of developing lung cancer over time. In addition, bronchoscopy was found to be useful for risk stratification strategies in lung cancer screening programs. Therefore, the use of bronchoscopy is increasing among patients with long-term dysplasia in France. Thus, with the effectiveness of bronchoscopes in lung cancer screening, the segment is expected to witness strong growth during the forecast period.
